Journal
HUMAN CELL
Volume 34, Issue 3, Pages 745-749Publisher
SPRINGER JAPAN KK
DOI: 10.1007/s13577-021-00503-5
Keywords
Erythropoiesis; CD34+cell; Mass spectrometry; Protein identification; Differentiation-related factor
Categories
Ask authors/readers for more resources
The production of red blood cells in vitro has been improved for basic or clinical research purposes. The study identified proteins showing reproducible differential expression during erythroid differentiation and found that most early-stage proteins were downregulated, while seven proteins showed upregulated expression in both bone marrow and cord blood cells. The roles of these proteins in erythropoiesis require further clarification, as they may contribute to erythroid differentiation.
The production of red blood cells in vitro, which is useful for basic or clinical research, has been improved. Further optimization of culture protocols may facilitate erythroid differentiation from hematopoietic stem cells to red blood cells. However, the details of erythropoiesis, particularly regarding the behaviors of differentiation-related proteins, remain unclear. Here, we performed erythroid differentiation using two independent bone marrow- or cord blood-derived CD34+ cell sources and identified proteins showing reproducible differential expression in all groups. Notably, most of the proteins expressed at the early stage were downregulated during erythroid differentiation. However, seven proteins showed upregulated expression in both bone marrow cells and cord blood cells. These proteins included alpha-synuclein and selenium-binding protein 1, the roles of which have not been clarified in erythropoiesis. There is a possibility that these factors contribute to erythroid differentiation as they maintained a high expression level. These findings provide a foundation for further mechanistic studies on erythropoiesis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available